Bladder cancer biomarker test company Pacific Edge executives fronted to questions from shareholders, at its annual meeting, over the company’s sustained losses, despite a year of reporting several commercial milestones.
The first of the biotech company’s shareholders to submit questions to
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
